A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Design Study to Evaluate the Effects of Perhexiline on ECG Parameters in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Perhexiline (Primary) ; Moxifloxacin
- Indications Hypertrophic cardiomyopathy
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Heart Metabolics Limited
- 30 Aug 2017 Results (n=52) presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
- 08 Jun 2016 Status changed from active, no longer recruiting to completed.
- 01 Jul 2015 Status changed from recruiting to active, no longer recruiting as rep[orted by Australian New Zealand Clinical Trials Registry.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History